994
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Expression and correlation analysis of silent information regulator 1 (SIRT1), sterol regulatory element-binding protein-1 (SREBP1), and pyroptosis factor in gestational diabetes mellitus

, , &
Article: 2311809 | Received 20 Sep 2023, Accepted 24 Jan 2024, Published online: 07 Feb 2024

References

  • Alberti KG, Zimmet PZ, WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):1–9. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S.
  • Abu SN, Jelinek HF, Alsafar H, et al. Genomics and epigenomics of gestational diabetes mellitus: understanding the molecular pathways of the disease pathogenesis. Int J Mol Sci. 2022;23(7):3514. doi: 10.3390/ijms23073514.
  • Johns EC, Denison FC, Norman JE, et al. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018;29(11):743–754. doi: 10.1016/j.tem.2018.09.004.
  • Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, et al. Gestational diabetes mellitus-recent literature review. J Clin Med. 2022;11(19):5736. doi: 10.3390/jcm11195736.
  • Sauve AA, Wolberger C, Schramm VL, et al. The biochemistry of sirtuins. Annu Rev Biochem. 2006;75(1):435–465. doi: 10.1146/annurev.biochem.74.082803.133500.
  • Ren H, Shao Y, Wu C, et al. Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway. Mol Cell Endocrinol. 2020;500:110628. doi: 10.1016/j.mce.2019.110628.
  • Cao Y, Jiang X, Ma H, et al. SIRT1 and insulin resistance. J Diabetes Complications. 2016;30(1):178–183. doi: 10.1016/j.jdiacomp.2015.08.022.
  • Debose-Boyd RA, Ye J. SREBPs in lipid metabolism, insulin signaling, and beyond. Trends Biochem Sci. 2018;43(5):358–368. doi: 10.1016/j.tibs.2018.01.005.
  • Xu J, Jiang Y, Wang J, et al. Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis. Cell Death Differ. 2014;21(8):1229–1239. doi: 10.1038/cdd.2014.40.
  • Olmos-Ortiz A, Flores-Espinosa P, Díaz L, et al. Immunoendocrine dysregulation during gestational diabetes mellitus: the central role of the placenta. Int J Mol Sci. 2021;22(15):8087. doi: 10.3390/ijms22158087.
  • Hod M, Kapur A, Sacks DA, et al. The international federation of gynecology and obstetrics (FIGO) initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131(Suppl 3):S173–S211. doi: 10.1016/S0020-7292(15)30007-2.
  • Mcintyre HD, Catalano P, Zhang C, et al. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. doi: 10.1038/s41572-019-0098-8.
  • Orning P, Lien E, Fitzgerald KA. Gasdermins and their role in immunity and inflammation. J Exp Med. 2019;216(11):2453–2465. doi: 10.1084/jem.20190545.
  • Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128.
  • Sollberger G, Strittmatter GE, Garstkiewicz M, et al. Caspase-1: the inflammasome and beyond. Vol. 20. London: SAGE Publications; 2014. p. 115–125. doi: 10.1177/1753425913484374.
  • Sborgi L, Rühl S, Mulvihill E, et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016;35(16):1766–1778. doi: 10.15252/embj.201694696.
  • Yu SY, Li XL. Pyroptosis and inflammasomes in obstetrical and gynecological diseases. Gynecol Endocrinol. 2021;37(5):385–391. doi: 10.1080/09513590.2021.1871893.
  • Lu S, Li Y, Qian Z, et al. Role of the inflammasome in insulin resistance and type 2 diabetes mellitus. Front Immunol. 2023;14:1052756. doi: 10.3389/fimmu.2023.1052756.
  • Hu T, Wang X, Ruan Y, et al. High glucose promotes the release of IL-1β and IL-18 from placental trophoblast by activating NLRP3 inflammasome. Chinese J Endocrinol Metab. 2022:38(01):36–41. doi: 10.3760/cma.j.cn311282-20210312-00158.
  • Schulze F, Wehner J, Kratschmar DV, et al. Inhibition of IL-1beta improves glycaemia in a mouse model for gestational diabetes. Sci Rep. 2020;10(1):3035. doi: 10.1038/s41598-020-59701-0.
  • Wang X, Sato R, Brown MS, et al. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 1994;77(1):53–62. doi: 10.1016/0092-8674(94)90234-8.
  • Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology – divergent pathophysiology. Nat Rev Endocrinol. 2017;13(12):710–730. doi: 10.1038/nrendo.2017.91.
  • Moon YA. The SCAP/SREBP pathway: a mediator of hepatic steatosis. Endocrinol Metab. 2017;32(1):6–10. doi: 10.3803/EnM.2017.32.1.6.
  • Petersen KF, Shulman GI. Etiology of insulin resistance. Am J Med. 2006;119(5 Suppl 1):S10–S16. doi: 10.1016/j.amjmed.2006.01.009.
  • Yan J, Li S, Zhang Y, et al. Cholesterol induces pyroptosis and matrix degradation via mSREBP1-drive endoplasmic reticulum stress in intervertebral disc degeneration. Front Cell Dev Biol. 2021;9:803132. doi: 10.3389/fcell.2021.803132.
  • Bronner DN, Abuaita BH, Chen X, et al. Endoplasmic reticulum stress activates the inflammasome via NLRP3- and caspase-2-driven mitochondrial damage. Immunity. 2015;43(3):451–462. doi: 10.1016/j.immuni.2015.08.008.
  • Lerner AG, Upton JP, Praveen PV, et al. IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab. 2012;16(2):250–264. doi: 10.1016/j.cmet.2012.07.007.
  • Hua S, Li Y, Su L, et al. Diosgenin ameliorates gestational diabetes through inhibition of sterol regulatory element-binding protein-1. Biomed Pharmacother. 2016;84:1460–1465. doi: 10.1016/j.biopha.2016.10.049.
  • Wang F, Yao S, Xia H. SIRT1 is a key regulatory target for the treatment of the endoplasmic reticulum stress-related organ damage. Biomed Pharmacother. 2020;130:110601. doi: 10.1016/j.biopha.2020.110601.
  • Wang LF, Wang XN, Huang CC, et al. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKalpha/SREBP1 signaling pathway. Lipids Health Dis. 2017;16(1):82. doi: 10.1186/s12944-017-0464-z.
  • Dong W LY, Liu B, et al. Resveratrol ameliorated cognitive function of diet-induced obesity mice through inhibiting pyroptosis mediated by NLRP3 inflammasome. Mod Prev Med. 2022;49(15):2814–2820. doi: 10.20043/j.cnki.MPM.202201313.
  • Ponugoti B, Kim DH, Xiao Z, et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem. 2010;285(44):33959–33970. doi: 10.1074/jbc.M110.122978.
  • Li Y, Yang X, He Y, et al. Negative regulation of NLRP3 inflammasome by SIRT1 in vascular endothelial cells. Immunobiology. 2017;222(3):552–561. doi: 10.1016/j.imbio.2016.11.002.
  • Ulubasoglu H, Hancerliogullari N, Tokmak A, et al. Low sirtuin-1 levels are associated with gestational diabetes mellitus. Minerva Endocrinol. 2023;48(3):282–287. doi: 10.23736/S2724-6507.22.03868-4.
  • Sin TK, Yung BY, Siu PM. Modulation of SIRT1-Foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance. Cell Physiol Biochem. 2015;35(2):541–552. doi: 10.1159/000369718.